RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the imaging industry, including picture archiving communications systems; and provides teleradiology services for remote interpretation of images on behalf of radiology groups, hospitals, and imaging center customers. As of December 31, 2017, it operated 297 facilities directly or indirectly through joint ventures with hospitals in California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

2.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

RadNet has received 53.19% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about RadNet and other stocks. Vote “Outperform” if you believe RDNT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RDNT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Do Wall Street analysts recommend investors buy shares of RadNet?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for RadNet.

When is RadNet's next earnings date?

How were RadNet's earnings last quarter?

RadNet Inc. (NASDAQ:RDNT) announced its quarterly earnings results on Monday, May, 11th. The medical research company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.17) by $0.16. The medical research company had revenue of $281.60 million for the quarter, compared to analysts' expectations of $242.09 million. RadNet had a return on equity of 1.56% and a net margin of 0.18%. The business's revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the company posted ($0.08) EPS. View RadNet's earnings history.

What guidance has RadNet issued on next quarter's earnings?

RadNet issued an update on its FY 2020
Pre-Market earnings guidance on Thursday, March, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.175-1.225 billion, compared to the consensus revenue estimate of $1.2 billion.

What price target have analysts set for RDNT?

1 Wall Street analysts have issued 1 year price objectives for RadNet's stock. Their forecasts range from $23.00 to $23.00. On average, they expect RadNet's share price to reach $23.00 in the next year. This suggests a possible upside of 28.8% from the stock's current price. View analysts' price targets for RadNet.

Has RadNet been receiving favorable news coverage?

News coverage about RDNT stock has been trending somewhat positive on Sunday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. RadNet earned a news sentiment score of 1.0 on InfoTrie's scale. They also gave media headlines about the medical research company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news aboutRadNet.

Are investors shorting RadNet?

RadNet saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,410,000 shares, an increase of 6.0% from the April 15th total of 1,330,000 shares. Based on an average trading volume of 482,500 shares, the short-interest ratio is presently 2.9 days. Approximately 3.3% of the shares of the company are sold short. View RadNet's Current Options Chain.

How do I buy shares of RadNet?

Shares of RDNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is RadNet's stock price today?

One share of RDNT stock can currently be purchased for approximately $17.86.

How big of a company is RadNet?

RadNet has a market capitalization of $905.32 million and generates $1.15 billion in revenue each year. The medical research company earns $14.76 million in net income (profit) each year or $0.29 on an earnings per share basis. RadNet employs 8,498 workers across the globe.